Seroprevalence of measles antibodies in women born between 1985 and 1999 in metropolitan city in India: a cross-sectional study
Introduction The Universal Immunisation Programme of India recommends first dose of measles vaccine in children at 9 months as the infant is protected by the maternal antibodies till then, and the vaccine provides optimal protection. However, during the recent outbreaks in 2023, in Mumbai, India, 31...
Saved in:
| Main Authors: | Rujuta Hadaye, Pradnya D Chandanshive, Nishat Khan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-12-01
|
| Series: | BMJ Public Health |
| Online Access: | https://bmjpublichealth.bmj.com/content/2/2/e001417.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A longitudinal study depicting persistence of COVID-19 antibodies after half a year using chemiluminescent microparticle immunoassay among healthcare workers and frontline workers in Mumbai, India’s largest metropoli
by: Rujuta S. Hadaye, et al.
Published: (2025-03-01) -
Seroprevalence of measles antibody among immigrants in Gwangju, South Korea
by: Ran Lee, et al.
Published: (2024-12-01) -
Measles seroprevalence in Thailand: are adolescents and young adults at risk of measles?
by: Panit Takkinsatian, et al.
Published: (2024-06-01) -
Seroprevalence of Measles, Rubella and Mumps Antibodies in Foreign Citizens Registered in Moscow Region (Labour Migrants)
by: T. A. Semenenko, et al.
Published: (2017-06-01) -
Measles, rubella, and mumps antibody seroprevalence among the children aged 18 years and younger in Karamay City, Xinjiang Uygur Autonomous Region
by: WU Meili, et al.
Published: (2025-03-01)